{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:20:15Z","timestamp":1790806815073,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10620-024-08767-1","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T14:28:13Z","timestamp":1733495293000},"page":"360-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth"],"prefix":"10.1007","volume":"70","author":[{"given":"Mar\u00eda Fernanda","family":"Garc\u00eda-Cedillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico Ulises","family":"Villegas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josealberto Sebastiano","family":"Arenas-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Jaqueline","family":"Ornelas-Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Kazuo","family":"Yamamoto-Furusho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alberto","family":"Estrella-Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Coss-Adame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"8767_CR1","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/s0140-6736(20)31548-8","volume":"396","author":"AC Ford","year":"2020","unstructured":"Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet 2020;396:1675\u20131688. https:\/\/doi.org\/10.1016\/s0140-6736(20)31548-8.","journal-title":"Lancet"},{"key":"8767_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fpsyt.2020.00664","volume":"11","author":"W Takakura","year":"2020","unstructured":"Takakura W, Pimentel M. Small intestinal bacterial overgrowth and irritable bowel syndrome\u2014an update. Front Psychiatry. 2020;11:664. https:\/\/doi.org\/10.3389\/fpsyt.2020.00664.","journal-title":"Front Psychiatry."},{"key":"8767_CR3","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1111\/j.1572-0241.2000.03368.x","volume":"95","author":"M Pimentel","year":"2000","unstructured":"Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000;95:3503\u20133506. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.03368.x.","journal-title":"Am J Gastroenterol."},{"key":"8767_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/s0002-9270(02)05902-6","volume":"98","author":"M Pimentel","year":"2003","unstructured":"Pimentel M. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003;98:412\u2013419. https:\/\/doi.org\/10.1016\/s0002-9270(02)05902-6.","journal-title":"Am J Gastroenterol."},{"key":"8767_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/j.1365-2036.2005.02506.x","volume":"21","author":"PR Gibson","year":"2005","unstructured":"Gibson PR, Shepherd SJ. Personal view: food for thought\u2014western lifestyle and susceptibility to Crohn\u2019s disease. The FODMAP hypothesis. Aliment Pharmacol Ther. 2005;21:1399\u20131409. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02506.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"8767_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/apt.15818","volume":"52","author":"PR Gibson","year":"2020","unstructured":"Gibson PR, Halmos EP, Muir JG. Review article: FODMAPS, prebiotics and gut health-the FODMAP hypothesis revisited. Aliment Pharmacol Ther. 2020;52:233\u2013246. https:\/\/doi.org\/10.1111\/apt.15818.","journal-title":"Aliment Pharmacol Ther."},{"key":"8767_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13527","volume":"31","author":"P Varj\u00fa","year":"2019","unstructured":"Varj\u00fa P, Gede N, Szak\u00e1cs Z et al. Lactose intolerance but not lactose maldigestion is more frequent in patients with irritable bowel syndrome than in healthy controls: a meta-analysis. Neurogastroenterol Motil. 2019;31:e13527. https:\/\/doi.org\/10.1111\/nmo.13527.","journal-title":"Neurogastroenterol Motil."},{"key":"8767_CR8","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/ajg.2013.198","volume":"108","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Zheng X, Cong Y et al. Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. Am J Gastroenterol. 2013;108:1516\u20131525. https:\/\/doi.org\/10.1038\/ajg.2013.198.","journal-title":"Am J Gastroenterol."},{"key":"8767_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1517\/13543780902780175","volume":"18","author":"M Pimentel","year":"2009","unstructured":"Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009;18:349\u2013358. https:\/\/doi.org\/10.1517\/13543780902780175.","journal-title":"Expert Opin Investig Drugs."},{"key":"8767_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ja.2014.106","volume":"67","author":"F Calanni","year":"2014","unstructured":"Calanni F, Renzulli C, Barbanti M, Viscomi GC. Rifaximin: beyond the traditional antibiotic activity. J Antibiot. 2014;67:667\u2013670. https:\/\/doi.org\/10.1038\/ja.2014.106.","journal-title":"J Antibiot."},{"key":"8767_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.13928","volume":"45","author":"L Gatta","year":"2017","unstructured":"Gatta L, Scarpignato C, McCallum RW et al. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther. 2017;45:604\u2013616. https:\/\/doi.org\/10.1111\/apt.13928.","journal-title":"Aliment Pharmacol Ther."},{"key":"8767_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1053\/j.gastro.2022.04.017","volume":"163","author":"A Lembo","year":"2022","unstructured":"Lembo A, Sultan S, Chang L, Heidelbaugh JJ, Smalley W, Verne GN. AGA Clinical practice guideline on the pharmacological management of irritable bowel syndrome with Diarrhea. Gastroenterology. 2022;163:137\u2013151. https:\/\/doi.org\/10.1053\/j.gastro.2022.04.017.","journal-title":"Gastroenterology."},{"key":"8767_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ajg.2017.46","volume":"112","author":"A Rezaie","year":"2017","unstructured":"Rezaie A, Buresi M, Lembo A et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112:775\u2013784. https:\/\/doi.org\/10.1038\/ajg.2017.46.","journal-title":"Am J Gastroenterol."},{"key":"8767_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1439-0396.2008.00841.x","volume":"93","author":"BP Willing","year":"2009","unstructured":"Willing BP, Kessel AGV. Intestinal microbiota differentially affect brush border enzyme activity and gene expression in the neonatal gnotobiotic pig. J Anim Physiol Anim Nutr. 2009;93:586\u2013595. https:\/\/doi.org\/10.1111\/j.1439-0396.2008.00841.x.","journal-title":"J Anim Physiol Anim Nutr."},{"key":"8767_CR15","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/j.micinf.2006.07.008","volume":"8","author":"H Kozakova","year":"2006","unstructured":"Kozakova H, Kolinska J, Lojda Z et al. Effect of bacterial monoassociation on brush-border enzyme activities in ex-germ-free piglets: comparison of commensal and pathogenic Escherichia coli strains. Microbes Infect. 2006;8:2629\u20132639. https:\/\/doi.org\/10.1016\/j.micinf.2006.07.008.","journal-title":"Microbes Infect."},{"key":"8767_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5056\/jnm22187","volume":"30","author":"W Takakura","year":"2024","unstructured":"Takakura W, Rezaie A, Chey WD, Wang J, Pimentel M. Symptomatic response to antibiotics in patients with small intestinal bacterial overgrowth: a systematic review and meta-analysis. J Neurogastroenterol Motil. 2024;30:7\u201316. https:\/\/doi.org\/10.5056\/jnm22187.","journal-title":"J Neurogastroenterol Motil."},{"key":"8767_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/mcg.0000000000001456","volume":"56","author":"AD Cano-Contreras","year":"2022","unstructured":"Cano-Contreras AD, Alfaro IJM, L\u00f3pez VMM et al. Efficacy of i3.1 probiotic on improvement of lactose intolerance symptoms. J Clin Gastroenterol 2022;56:141\u2013147. https:\/\/doi.org\/10.1097\/mcg.0000000000001456.","journal-title":"J Clin Gastroenterol"},{"key":"8767_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12602-018-9507-7","volume":"12","author":"R Gingold-Belfer","year":"2020","unstructured":"Gingold-Belfer R, Levy S, Layfer O et al. Use of a novel probiotic formulation to alleviate lactose intolerance symptoms\u2014a pilot study. Probiotics Antimicrob Proteins. 2020;12:112\u2013118. https:\/\/doi.org\/10.1007\/s12602-018-9507-7.","journal-title":"Probiotics Antimicrob Proteins."},{"key":"8767_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/nejmoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel M, Lembo A, Chey WD et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22\u201332. https:\/\/doi.org\/10.1056\/nejmoa1004409.","journal-title":"N Engl J Med."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08767-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08767-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08767-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T08:08:56Z","timestamp":1737706136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08767-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["8767"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08767-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest regarding this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was conducted in full compliance with the ethical guidelines and regulations set forth by the institutional research and ethics committee (Comit\u00e9 de Investigaci\u00f3n del Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubiran and Comit\u00e9 de \u00c9tica en Investigaci\u00f3n del Insituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubiran, REF. 2959). This study adhered to the ethical principles outlined in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}